
Abera Bioscience AB
ABERA | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0015245097
- LEI:
- 549300IO3Q8IE2FDUS29
- Country:
- Sweden
- Address:
- BOX 1747, 751 47 Uppsala
- Website:
- https://aberabio.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
No filings match the current criteria. |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
![]() |
Aptahem AB | Sweden | APTA | |
![]() |
Arctic Bioscience | Norway | ABS | |
![]() |
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
![]() |
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
![]() |
AroCell AB | Sweden | AROC | |
![]() |
Arterra Bioscience | Italy | ABS | |
|
Ascelia Pharma | Sweden | ACE |